The role of per cent predicted 6-min walk distance in pulmonary arterial hypertension

Lee W-T.N., Peacock A.J., Johnson M.K.

Source: Eur Respir J 2010; 36: 1294-1301
Journal Issue: December
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Lee W-T.N., Peacock A.J., Johnson M.K.. The role of per cent predicted 6-min walk distance in pulmonary arterial hypertension. Eur Respir J 2010; 36: 1294-1301

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The prognostic value of percent predicted six-minute walk distance in pulmonary arterial hypertension
Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension
Year: 2009




The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertension
Source: Eur Respir Rev 2013; 22: 487-494
Year: 2013



The 6-min walk distance: change over time and value as a predictor of survival in severe COPD
Source: Eur Respir J 2004; 23: 28-33
Year: 2004



Role of exercise cardiac index to predict NYHA functional class, 6-minute walk test distance and survival in idiopathic, heritable and anorexigen-associated pulmonary arterial hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011

Physiological response to the six-minute walk test in pulmonary arterial hypertension
Source: Eur Respir J 2005; 26: 667-672
Year: 2005



The 6-minute walk test adjusted for peak heart rate correlates with stroke volume index in pulmonary arterial hypertension
Source: Annual Congress 2004 - Pulmonary hypertension
Year: 2004


Relationship between sit-to-stand test and six-minute walk test in patients with pulmonary arterial hypertension
Source: International Congress 2015 – The challenge of choosing the best physical and functional assessment methods
Year: 2015

Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension
Source: Eur Respir J 2006; 27: 114-120
Year: 2006



Maximal cardiopulmonary exercise testing in mildly symptomatic patients with idiopathic pulmonary arterial hypertension: correlations with 6-min walk distance and resting hemodynamics
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009

Is 6-minute walk distance (6MWD) associated with long-term outcomes in pulmonary arterial hypertension (PAH)? Results from SERAPHIN
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

What is the role of hypoxaemia, 6-minute walk test, diffusion capacity, pulmonary arterial hypertension in diffuse interstitial lung diseases?
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009

Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension
Source: Eur Respir J 2001; 17: 647-652
Year: 2001



Effects of sildenafil on 6-minute walk distance (6MWD) and WHO functional class (FC) in pulmonary arterial hypertension (PAH) patients after 1 year of treatment
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005


Serious adverse events during a 6-min walk test in patients with pulmonary hypertension
Source: Eur Respir J 2015; 45: 1179-1182
Year: 2015


The 6-min walking distance: long-term follow up in patients with COPD
Source: Eur Respir J 2007; 29: 535-540
Year: 2007



Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension
Source: Eur Respir J 2012; 40: 1410-1419
Year: 2012



6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2014; 43: 1421-1429
Year: 2014



6-minute walk distance as a predictor of outcome in idiopathic pulmonary fibrosis
Source: Eur Respir J 2014; 43: 1823-1824
Year: 2014


6-minute walk distance as a predictor of outcome in idiopathic pulmonary fibrosis
Source: Eur Respir J 2014; 43: 1822-1823
Year: 2014


Using the six-minute walk test to assess exercise capacity in people with pulmonary hypertension
Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation
Year: 2012